3418-45-9 Usage
Uses
Used in Pharmaceutical Industry:
3-Quinolinol,1,2,3,4-tetrahydrois used as a key intermediate in the synthesis of various pharmaceuticals for its ability to form complex molecular structures that can target specific biological pathways.
Used in Agrochemical Industry:
3-Quinolinol,1,2,3,4-tetrahydrois used as a building block in the development of agrochemicals, contributing to the creation of effective compounds for pest and disease control in agriculture.
Used in Antimicrobial and Antifungal Applications:
3-Quinolinol,1,2,3,4-tetrahydrois used as an antimicrobial and antifungal agent, leveraging its potential to inhibit the growth of harmful microorganisms, thereby offering a means to control infections and maintain hygiene.
Used in Neurodegenerative Disease Treatment:
3-Quinolinol,1,2,3,4-tetrahydrois used in the research and development of treatments for neurodegenerative diseases, due to its potential to interact with neurological pathways and offer therapeutic benefits.
Used in Metal Extraction and Purification:
3-Quinolinol,1,2,3,4-tetrahydrois used as a chelating agent in the extraction and purification of metals, facilitating the separation and concentration of metal ions in various industrial processes.
Used in Metalworking Fluids:
3-Quinolinol,1,2,3,4-tetrahydrois used as a corrosion inhibitor in metalworking fluids, helping to prevent the deterioration of metal surfaces during manufacturing and machining processes.
Environmental Considerations:
3-Quinolinol,1,2,3,4-tetrahydrois considered a potential environmental hazard and has been subject to environmental risk assessments due to its potential toxicity to aquatic organisms, necessitating careful handling and disposal to minimize ecological impact.
Check Digit Verification of cas no
The CAS Registry Mumber 3418-45-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,1 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3418-45:
(6*3)+(5*4)+(4*1)+(3*8)+(2*4)+(1*5)=79
79 % 10 = 9
So 3418-45-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO/c11-8-5-7-3-1-2-4-9(7)10-6-8/h1-4,8,10-11H,5-6H2
3418-45-9Relevant academic research and scientific papers
Double Hydroboration of Quinolines via Borane Catalysis: Diastereoselective One Pot Synthesis of 3-Hydroxytetrahydroquinolines
Kim, Eunae,Jeon, Hyun Ji,Park, Sehoon,Chang, Sukbok
supporting information, p. 308 - 313 (2019/11/13)
Described herein is an organoborane-catalysed consecutive borylative reduction of quinolines and isoquinolines to furnish tetrahydro(iso)quinolines bearing a C(sp3)?B bond β to the nitrogen atom. The installed C?B bond is oxidatively transformed to the hydroxy group in one pot. The present double hydroboration is proposed to proceed via a stepwise ionic mechanism involving a boronium ion. The stereo-outcome was found to be dependent on the position (C2 vs C4) of the substituents in quinolines. (Figure presented.).
β-Hydroxy-tetrahydroquinolines from Quinolines Using Chloroborane: Synthesis of the Peptidomimetic FISLE-412
Altiti, Ahmad S.,Cheng, Kai Fan,He, Mingzhu,Al-Abed, Yousef
supporting information, p. 10738 - 10743 (2017/08/22)
A new synthetic protocol provides a simple and direct method to generate functionalized β-hydroxy-tetrahydroquinolines (THQs). Hydroboration of quinolines using chloroboranes followed by oxidation with NaBO3?H2O led to the formation of functionalized β-hydroxy THQs. High regio- and diastereoselectivities were observed in α and γ substituted quinolines and the trans diastereomer of the β-hydroxy-THQ was the major isostere. This new protocol was utilized to build the novel antibody-targeted lupus peptidomimetic, FISLE-412.
4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS
-
Page/Page column 266, (2016/06/14)
The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.